Physician profile
Matthew Britt
NPI 1104164896
$102,580.89
in general payments reported to CMS, 2019-2025
39 companies · $2,179 in 2025
The $2,179 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $17K · 2021: $15K · 2022: $16K · 2023: $35K · 2024: $7,665 · 2025: $2,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Food and Beverage: $5,829 · Travel and Lodging: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,875.00 |
| Food and Beverage | $5,828.68 |
| Travel and Lodging | $369.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $43,564.84 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Eminent Spine, LLC | $27,040.00 | 2023-2024 | Eminent Foot Plate Systems |
| Anika Therapeutics, INC. | $12,636.83 | 2020-2023 | Tactoset |
| Smith+Nephew, INC. | $9,518.15 | 2020-2025 | Panta 2, Cadence, Uni Cp |
| Stryker Corporation | $2,013.80 | 2019-2025 | Citrefix, Infinity Adaptis, Inbone |
| Vilex LLC | $1,087.42 | 2022 | |
| Horizon Therapeutics Plc | $1,073.98 | 2019-2023 | Krystexxa |
| 4web, INC. | $990.01 | 2022-2024 | Spine Truss System |
| Paragon 28, INC. | $891.00 | 2021-2024 | Bun-Yo-Matic |
| Pylant Medical | $839.52 | 2019-2024 | |
| Amgen INC. | $638.45 | 2024-2025 | Krystexxa |
| Wright Medical Technology, INC. | $317.09 | 2019-2020 | |
| Sandoz INC. | $289.62 | 2019-2020 | |
| Abbott Laboratories | $238.58 | 2019-2023 | Diamondback Peripheral |
| Paratek Pharmaceuticals, INC. | $165.29 | 2021-2025 | Nuzyra |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $156.88 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Durolane |
| Orthofix Medical, INC. | $147.94 | 2021-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $147.00 | 2020-2024 | Orthovisc, Monovisc |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $101.75 | 2022-2024 | Jublia |
| Ossio INC | $88.01 | 2022 | |
| Normatec Industries, LP | $75.58 | 2019-2020 | |
| Treace Medical Concepts, INC. | $72.70 | 2024-2025 | |
| Organogenesis INC. | $67.97 | 2021-2024 | |
| In2bones USA, LLC | $60.55 | 2020 | |
| Nabriva Therapeutics, Plc | $49.52 | 2021-2022 | |
| Medshape, INC. | $47.73 | 2022 | |
| Biotissue Holdings INC. | $37.10 | 2021-2022 | |
| Axogen | $30.86 | 2025 | |
| Kerecis Limited | $22.92 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $21.50 | 2025 | Exparel |
| Solventum Corporation | $21.01 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Acumed LLC | $20.28 | 2019 | |
| Kci USA, INC. | $17.80 | 2019 | |
| Access Pro Medical, LLC | $17.06 | 2023 | Matriderm |
| Nevro Corp. | $16.78 | 2023 | Senza |
| Mimedx Group, INC. | $16.48 | 2024 | |
| Ibsa Pharma INC. | $14.06 | 2024 | Tirosint, Flector, Licart |
| Merck Sharp & Dohme LLC | $12.83 | 2019 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Britt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.